
Management of hepatitis C virus in special populations: Patient and treatment considerations
Keywords: ESLD; end-stage liver disease; HAART; highly active antiretroviral therapy; HCC; hepatocellular carcinoma; HIV; human immunodeficiency virus; IFN; interferon; IVDU; intravenous drug user; NHANES; National Health and Nutrition Examination Survey; NIH; Nati